Clinical Trials on Cerebral Perfusion in Australia

Total 151 results

Svehlik Martin, MD PhD
University of Graz

Completed

A Prospective Study of Two Home Based Muscle Strengthening Programs for Children With Cerebral Palsy

Cerebral Palsy

Austria
Neuroscience Trials Australia

Completed

STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial (STOP-AUST)

Stroke | Intracerebral Haemorrhage

Australia, Finland
Medical University of Graz

Enrolling by invitation

Tracking General Movements

Cerebral Palsy | Clinical Reasoning | General Movement Assessment

Austria
UCB S.A. - Pharma Sector

Terminated

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Acute Ischaemic Middle Cerebral Artery Stroke

Sweden, Argentina, Austria, Belgium, France, Germany, Greece, Hungary, Italy, Norway, Poland, Singapore, Spain, Taiwan, Turkey
Connecticut Children's Medical Center
Yale University; Columbia University; Gold Coast Hospital and Health Service; Newark... and other collaborators

Recruiting

Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound

Septic Arthritis | Hip Effusion | Transient Synovitis, Hip

United States, Australia
Synthes GmbH

Completed

Study on the Treatment of Osteoporotic Vertebral Fractures Using Vertebral Body Stenting

Vertebral Body Fractures

Germany, Austria
Medical University of Graz
Medical University Innsbruck; Paracelsus Medical University

Recruiting

Reperfusion Injury After Endovascular Stroke Treatment

Ischemic Stroke

Austria
Medical University Innsbruck

Unknown

Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment (RIPAT)

Cerebral Aneurysm

Austria
DiaMedica Therapeutics Inc

Completed

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke (ReMEDy1)

Acute Ischemic Stroke

Australia
University of Zurich

Recruiting

Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury (HeMoVal)

Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Vasospasm | Delayed Ischemic Neurological Deficit

Switzerland, Germany, Austria
The George Institute
National Health and Medical Research Council, Australia

Completed

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT2)

Stroke | Hypertension | Intracerebral Hemorrhage

United States, France, Australia, Hong Kong, Finland, Germany, Spain, Argentina, Austria, Belgium, Brazil, Chile, China, India, Italy, Pakistan, Portugal, Switzerland, United Kingdom
Medical University Innsbruck

Recruiting

Prevention of Vasospasm in SAH Through CSF Treatment (PREVAIL)

Subarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, Cerebral

Austria
Neuroscience Trials Australia
National Health and Medical Research Council, Australia; Monash University

Active, not recruiting

Trial of EXenatide in Acute Ischaemic Stroke (TEXAIS)

Acute Ischemic Stroke

Australia, Finland, New Zealand
Medical University of Vienna

Completed

Cerebral Microembolism During Hemodialysis

Cerebral Embolism | Complication of Dialysis | Thrombus Due to Renal Dialysis Device, Implant, or Graft

Austria
Amicus Therapeutics

Completed

A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects

Fabry Disease

Australia
4D Molecular Therapeutics

Active, not recruiting

4D-310 in Adults With Fabry Disease and Cardiac Involvement

Fabry Disease

Taiwan, Australia
Amicus Therapeutics

Completed

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Fabry Disease

Australia, Brazil
Karl Landsteiner University of Health Sciences
Paracelsus Medical University

Completed

Medication Intake of Solid Dosage Forms: A Risk Factor for Patients With Stroke-induced Dysphagia? (MedISID)

Stroke | Dysphagia | Cerebral Infarction | Stroke, Acute

Austria
Novo Nordisk A/S

Completed

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Acquired Bleeding Disorder | Intracerebral Haemorrhage

Spain, Sweden, Singapore, Norway, Italy, Switzerland, Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Netherlands, United Kingdom
University College, London
University of Sydney; University Hospital Birmingham

Unknown

Native T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Rare Diseases (FABRY400)

Fabry Disease

United Kingdom, Australia
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Recurrent Childhood Ependymoma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood Cerebellar Astrocytoma | Recurrent Childhood Cerebral Astrocytoma | Recurrent Childhood Subependymal Giant Cell Astrocytoma | Childhood Mixed Glioma | Childhood Oligodendroglioma and other conditions

United States, Canada, Australia
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units

Intracerebral Haemorrhage

Australia, Finland, Taiwan, New Zealand, Vietnam
Melbourne Health
Sanofi

Withdrawn

Complement Activation in the Lysosomal Storage Disorders (CATALYST)

Lysosomal Storage Diseases | Fabry Disease | Niemann-Pick Disease, Type C | Gaucher Disease

Australia
Neurobiological Technologies

Terminated

ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

United States, Australia, Israel, South Africa, Slovakia, New Zealand, Austria, Czech Republic, Poland, Russian Federation, Switzerland
Sanofi

Completed

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Acute Ischemic Stroke

Korea, Republic of, Italy, Brazil, Canada, Colombia, Israel, Mexico, Poland, Czech Republic, United States, Australia, Austria, India, South Africa, Turkey
Neurobiological Technologies

Terminated

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

Taiwan, United States, Australia, South Africa, Canada, Czech Republic, Netherlands, Poland, Russian Federation, United Kingdom
Medical University of Vienna
Karl Landsteiner Institute for Clinical Epilepsy Research

Recruiting

Multimodal Neuromonitoring (MMNM)

Seizures | Traumatic Brain Injury | Subarachnoid Hemorrhage | Intracerebral Hemorrhage | Cortical Spreading Depolarization and Depression | Ictal-Interictal Continuum

Austria
Penumbra Inc.

Active, not recruiting

MIND: Artemis in the Removal of Intracerebral Hemorrhage

Cerebral Hemorrhage | Intracerebral Hemorrhage | Brain Hemorrhage | Cerebral Parenchymal Hemorrhage

United States, Germany, Canada, Austria
Amicus Therapeutics

Completed

Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease

Fabry Disease

France, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
University of Zurich
Swiss National Science Foundation

Active, not recruiting

Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair)

Intraventricular Hemorrhage of Prematurity

Switzerland, Austria
Stryker Neurovascular

Completed

Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO) (TREVO)

Ischemic Stroke

Spain, Sweden, Germany, Austria
C. R. Bard
Boston University; Yale University

Terminated

Impact of Fever Prevention in Brain Injured Patients (INTREPID)

Ischemic Stroke | Fever | Subarachnoid Hemorrhage | Intracerebral Hemorrhage

Korea, Republic of, United States, Germany, Switzerland, Austria, Australia
Klinikum Wels-Grieskirchen
Genzyme, a Sanofi Company

Completed

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Focus of Study: Prevalence of Fabry Disease in CKD Population

Austria
Merz Pharmaceuticals GmbH

Completed

Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy

Lower Limb Spasticity Due to Cerebral Palsy

Poland, Austria, Czechia, Estonia, France, Germany, Israel, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine
AVROBIO

Terminated

Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201

Fabry Disease

Australia, Brazil
Novo Nordisk A/S

Completed

Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage

Acquired Bleeding Disorder | Intracerebral Haemorrhage

Finland, Singapore, Australia, Spain, Denmark, Germany, Italy, Taiwan, United Kingdom
Fibrex Medical Research & Development GmbH

Completed

Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury

Myocardial Infarction | Myocardial Ischemia | Coronary Disease

Austria, Belgium, Czech Republic, Denmark, Germany, Lithuania, Netherlands, Poland, Romania, Sweden, Switzerland
Cambridge University Hospitals NHS Foundation Trust
University of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...

Completed

Rituximab Vasculitis Maintenance Study (RITAZAREM)

Microscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener Granulomatosis

United States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
Medical University of Vienna
Medical University of Graz

Unknown

Viennese Prevalence Study of Anderson-Fabry Disease (VIEPAF)

Fabry Disease | Left Ventricular Hypertrophy

Austria
bluebird bio

Completed

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD)

United States, Germany, Argentina, Australia, France, United Kingdom
University Hospitals Cleveland Medical Center
The University of Texas Health Science Center, Houston; Stryker Neurovascular

Completed

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT2)

Acute Ischemic Stroke

Spain, United States, Canada, Australia, New Zealand, Switzerland
Amicus Therapeutics

Approved for marketing

Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease

Fabry Disease

United States, Australia
Invex Therapeutics Ltd.
Premier Research Group plc; University Hospitals Birmingham Neuro Ophthalmology... and other collaborators

Terminated

A Trial to Determine the Efficacy and Safety of Presendin in IIH (IIH EVOLVE)

Idiopathic Intracranial Hypertension

Israel, Germany, Australia, United States, United Kingdom, New Zealand
Sabine Rhode
Ruhr University of Bochum

Unknown

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) (PIPACRegis)

Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural Cancer

Singapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
Merz Pharmaceuticals GmbH

Completed

Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy

Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy

Poland, Austria, Czechia, Estonia, Germany, Israel, Korea, Republic of, Romania, Russian Federation, Slovakia, Turkey, Ukraine
Dr. Markus Alfred Möhlenbruch
Microvention-Terumo, Inc.; Eppdata Hamburg

Completed

Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke (SESAME)

Stroke, Acute | Cerebral Stroke | Cerebrovascular Stroke

Germany, Austria, France, Italy, Netherlands
Danube University Krems
NÖ Forschungs- und Bildungsges.m.b.H (NFB)

Completed

Austrian Polyintervention Study to Prevent Cognitive Decline After Ischemic Stroke (ASPIS)

Ischemic Stroke | Dementia | Cognitive Decline

Austria
University Hospital Birmingham NHS Foundation Trust
Northern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaborators

Active, not recruiting

Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease (RaILRoAD)

Fabry Disease

United Kingdom, Australia
Holland Bloorview Kids Rehabilitation Hospital
The Hospital for Sick Children

Recruiting

Cerebral Palsy Hip Outcomes Project - International Multi-centre Study

Cerebral Palsy

Denmark, Canada, United States, Australia, Israel, Korea, Republic of, New Zealand, Poland, Sweden, United Kingdom
The George Institute
The University of New South Wales

Recruiting

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)

Hypertension | Intracerebral Haemorrhage (ICH)

United Kingdom, Australia, Singapore, Georgia, Netherlands, Nigeria, Sri Lanka, Switzerland, Brazil, Malaysia, Taiwan, Vietnam

Clinical Trials on Cerebral Perfusion in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations